Advertisement
Akebia Therapeutics Resubmits NDA For Vadadustat To FDA
(RTTNews) - Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.
Vadadustat, Akebia's investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is currently approved for use in 35 countries.
Based on standard NDA resubmission review timelines, a letter from the FDA acknowledging that the resubmission is complete, classifying the resubmission, and setting the PDUFA date is expected in 30 days. Akebia expects the FDA to set a PDUFA date of six months from the date of submission.
For More Such Health News, visit rttnews.com
read more
Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3
Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday that the company expects to resubmit its New Drug Application (NDA) for vadadustat as a treatment for anemia due to chronic kidney disease in adult patients on dialysis by the end of the third quarter of 2023.
RTTNews
|
712 gün önce
Sensex, Nifty Little Changed In Early Trade
Indian shares were little changed in cautious trade on Wednesday after U.S. President Donald Trump threatened to raise tariffs on Indian goods "very substantially" within 24 hours, citing India's continued purchases of Russian oil.
RTTNews
|
38 dakika önce
European Economic News Preview: Germany Factory Orders Data Due
Factory orders and construction purchasing managers' survey data from Germany and retail sales from the euro area are the top economic news due on Wednesday. At 2.00 am ET, Destatis is scheduled to issue Germany's factory orders data for June. Orders are forecast to grow 1.0 percent month-on-month, in contrast to the 1.4 percent fall in May.
RTTNews
|
53 dakika önce
Australian Market Maintains Early Gains In Mid-market
The Australian stock market is maintaining its early gains in mid-market moves on Wednesday, extending to the gains in the previous two sessions, with the benchmark S&P/ASX 200 moving above the 8,800 level to all-time record highs, despite the broadly negative cues from Wall Street overnight, with gains across most sectors led by mining and financial stocks.
RTTNews
|
1s 44 dakika önce
Asian Markets Track Wall Street Lower
Asian stock markets are trading mostly lower on Wednesday, following the broadly negative cues from Wall Street overnight, amid the ongoing trade concerns following US President Donald Trump's latest comments on tariffs. Trump said he will be announcing new tariffs on semiconductors and chips as well as up to 250 percent on pharmaceuticals imported into the U.S.
RTTNews
|
2s 8 dakika önce
Sensex, Nifty Likely To Open On Flat Note On Tariff Worries
Indian shares look set to open on a flat note Wednesday as investors react to U.S. President Donald Trump's latest tariff threats and await the Reserve Bank of India's policy announcement, with investors expecting a rate pause and dovish signals to offset rising external risks.
RTTNews
|
2s 40 dakika önce
Lower Open Called For Thai Stock Market
The Thai stock market has moved higher in back-to-back sessions, gathering almost 30 points or 2.5 percent along the way. The Stock Exchange of Thailand now sits just above the 1,245-point plateau and it's expected to open under pressure on Wednesday.
RTTNews
|
3s 13 dakika önce
Japanese Market Slightly Higher
The Japanese stock market is slightly higher on Wednesday after opening well in the red, extending the gains in the previous session, despite the broadly negative cues from Wall Street overnight. The Nikkei 225 is moving well above the 40,550 level, with gains in automakers, exporters and financial stocks partially offset by weakness in technology stocks.
RTTNews
|
3s 35 dakika önce
